You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALK negative mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Activating ALK Gene Mutation Negative, Activating EGFR Gene Mutation Negative, Activating ROS1 Gene Mutation Negative Trial in

Completed
  • Activating ALK Gene Mutation Negative
  • +7 more
  • Counseling
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022

Non Small Cell Lung Cancer Trial (Toripalimab, Toripalimab mimetic ())

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Feb 23, 2021

ALK Phosphorylation Trial in Harbin (crizotinib for rearrangement-negative, high phosphorylated ALK patients)

Completed
  • ALK Phosphorylation
  • crizotinib for rearrangement-negative, high phosphorylated ALK patients
  • Harbin, Heilongjiang, China
    Harbin Medical University Cancer Hospital
Mar 19, 2023

TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in United States (Sterotactic Body

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +6 more
  • Sterotactic Body Radiotherapy/SBRT
  • Standard of care
  • Basking Ridge, New Jersey
  • +8 more
Jul 26, 2022

NSCLC (NSCLC) Trial in China (Capmatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Xiamen, Fujian, China
  • +18 more
Jan 27, 2023

Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

Recruiting
  • Her-2 Negative Breast Cancer
  • HRR Gene Mutation
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Mar 7, 2023

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Radiotherapy Side Effect, NSCLC, ALK Gene Mutation Trial in Stockholm (SBRT/SRS/radiation therapy)

Not yet recruiting
  • Radiotherapy Side Effect
  • +2 more
  • SBRT/SRS/radiation therapy
  • Stockholm, Sweden
    Karolinska University Hospital
Feb 16, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

ALK Gene Mutation, Lung Adenocarcinoma, Immunotherapy Trial in Changsha (Pembrolizumab Combined With Bevacizumab and

Not yet recruiting
  • ALK Gene Mutation
  • +2 more
  • Pembrolizumab Combined With Bevacizumab and Chemotherapy
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jul 14, 2022

Either EML4-ALK Gene Rearrangements or T790M EGFR Mutation in

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Hollywood, Florida
    • +1 more
    Sep 29, 2021

    NSCLC Stage IIIB, ALK Gene Mutation Trial in Mexico City (Alectinib Oral Product)

    Recruiting
    • Non-small Cell Lung Cancer Stage IIIB
    • ALK Gene Mutation
    • Alectinib Oral Product
    • Mexico City, Mexico
      Thoracic Oncology Unit and Personalized Medicine Laboratory, Ins
    Jan 26, 2023

    Carotid Plaque Burden in Philadelphia Negative

    Recruiting
    • Myeloproliferative Neoplasm
      • Sohag, Egypt
        Faculty of Medicine
      Aug 14, 2023

      NSCLC Trial in Guangzhou (Ensartinib, Bevacizumab)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-Sen University Cancer Center
      Aug 4, 2022

      Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

      Not yet recruiting
      • Lung Adenocarcinoma
      • +3 more
      • Serplulimab and Bevacizumab injection
      • (no location specified)
      Dec 21, 2022

      Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (NVL-655)

      Recruiting
      • Locally Advanced Solid Tumor
      • Metastatic Solid Tumor
      • Orange, California
      • +13 more
      Jan 31, 2023

      PD-1 Antibody Plus Chemotherapy for TKI Failure Driver Gene

      Recruiting
      • Non Small Cell Lung Cancer
        • Changsha, Hunan, China
          Yongchang Zhang
        Mar 9, 2022

        Growth Disorders Trial in Washington (Somatropin)

        Enrolling by invitation
        • Growth Disorders
        • Washington, District of Columbia
          Children's National Hospital
        Aug 29, 2022

        BRCA and NACT in TNBC Patients

        Completed
        • Triple-Negative Breast Cancer
        • BRCA1/2 genetic testing
        • Rome, RM, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Feb 20, 2023

        Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

        Active, not recruiting
        • Non Small Cell Lung Cancer
        • +5 more
        • Orange, California
        • +13 more
        Nov 7, 2022

        Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

        Recruiting
        • Advanced Breast Cancer
        • Thalassery, Kerala, India
          Novartis Investigative Site
        Nov 21, 2022

        Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory

        Withdrawn
        • Advanced Malignant Neoplasm
        • +10 more
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Feb 15, 2022

        Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • +7 more
        • (no location specified)
        Aug 1, 2022

        BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

        Recruiting
        • BARD1 Gene Mutation
        • +14 more
        • Educational Intervention
        • +3 more
        • Houston, Texas
        • +1 more
        Jun 14, 2022

        Lung Cancer, EGFR Gene Mutation, EGFR Trial in Charlottesville (Sensus Smartwatch Application, RX Cap, Fitbit Sense)

        Recruiting
        • Lung Cancer
        • +3 more
        • Sensus Smartwatch Application
        • +3 more
        • Charlottesville, Virginia
          University of Virginia
        Aug 26, 2022